Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

MGMT Leu84Phe polymorphism contributes to cancer susceptibility: evidence from 44 case-control studies.

Liu J, Zhang R, Chen F, Yu C, Sun Y, Jia C, Zhang L, Salahuddin T, Li X, Lang J, Song X.

PLoS One. 2013 Sep 26;8(9):e75367. doi: 10.1371/journal.pone.0075367. eCollection 2013.

2.

Effects of O6-methylguanine-DNA methyltransferase (MGMT) polymorphisms on cancer: a meta-analysis.

Zhong Y, Huang Y, Huang Y, Zhang T, Ma C, Zhang S, Fan W, Chen H, Qian J, Lu D.

Mutagenesis. 2010 Jan;25(1):83-95. doi: 10.1093/mutage/gep050. Epub 2009 Nov 5.

PMID:
19892775
3.

DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas.

Felini MJ, Olshan AF, Schroeder JC, North KE, Carozza SE, Kelsey KT, Liu M, Rice T, Wiencke JK, Wrensch MR.

Neuroepidemiology. 2007;29(1-2):55-8. Epub 2007 Sep 24.

PMID:
17898525
4.

MGMT Leu84Phe gene polymorphism and lung cancer risk: a meta-analysis.

Qiu ZX, Xue F, Shi XF, He X, Ma HN, Chen L, Chen PZ.

Tumour Biol. 2014 May;35(5):4381-7. doi: 10.1007/s13277-013-1576-3. Epub 2014 Jan 5.

PMID:
24390665
5.

The polymorphisms in the MGMT gene and the risk of cancer: a meta-analysis.

Du L, Wang H, Xiong T, Ma Y, Yang J, Huang J, Zeng D, Wang X, Huang H, Huang J.

Tumour Biol. 2013 Oct;34(5):3227-37. doi: 10.1007/s13277-013-0893-x. Epub 2013 Jun 13.

PMID:
23760981
6.

Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.

Hu Z, Wang H, Shao M, Jin G, Sun W, Wang Y, Liu H, Wang Y, Ma H, Qian J, Jin L, Wei Q, Lu D, Huang W, Shen H.

Hum Mutat. 2007 May;28(5):431-40.

PMID:
17285603
7.

Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.

Hu Y, Zhou M, Li K, Zhang K, Kong X, Zheng Y, Li J, Liu L.

Tumour Biol. 2014 Mar;35(3):1715-25. doi: 10.1007/s13277-013-1320-z. Epub 2013 Nov 8. Review.

PMID:
24203816
8.

Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma.

Huang J, Ye F, Chen H, Lu W, Xie X.

Carcinogenesis. 2007 Jun;28(6):1314-22. Epub 2007 Jan 18.

PMID:
17234722
9.

Association of survivin polymorphisms with tumor susceptibility: a meta-analysis.

Zhu Y, Li Y, Zhu S, Tang R, Liu Y, Li J.

PLoS One. 2013 Sep 30;8(9):e74778. doi: 10.1371/journal.pone.0074778. eCollection 2013.

10.

Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.

Zhang Z, Wang L, Wei S, Liu Z, Wang LE, Sturgis EM, Wei Q.

DNA Repair (Amst). 2010 May 4;9(5):558-66. doi: 10.1016/j.dnarep.2010.02.006. Epub 2010 Mar 4.

11.

FASLG polymorphism is associated with cancer risk.

Liu Y, Wen QJ, Yin Y, Lu XT, Pu SH, Tian HP, Lou YF, Tang YN, Jiang X, Lu GS, Zhang J.

Eur J Cancer. 2009 Sep;45(14):2574-8. doi: 10.1016/j.ejca.2009.04.001. Epub 2009 May 4. Review.

PMID:
19403301
12.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3. Epub 2010 Dec 2.

PMID:
21127985
13.

TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis.

Chen B, Liu S, Wang XL, Xu W, Li Y, Zhao WH, Wu JQ.

Eur J Cancer. 2009 Sep;45(14):2598-605. doi: 10.1016/j.ejca.2009.06.023. Epub 2009 Jul 28. Review.

PMID:
19643596
14.

Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis.

Meng Q, Zhang J, Lian B, Song C.

Tumour Biol. 2014 Mar;35(3):2367-72. doi: 10.1007/s13277-013-1312-z. Epub 2013 Nov 1.

PMID:
24178910
15.

Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.

Qi X, Zhang F, Yang X, Fan L, Zhang Y, Chen L, Zhou Y, Chen X, Zhong L, Jiang J.

Breast Cancer Res Treat. 2010 Jul;122(1):273-9. doi: 10.1007/s10549-010-0847-6. Epub 2010 Mar 23.

PMID:
20309626
16.

Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.

Zou YF, Wang F, Feng XL, Tian YH, Tao JH, Pan FM, Huang F.

Eur J Cancer. 2011 May;47(7):1072-9. doi: 10.1016/j.ejca.2010.11.034. Epub 2011 Jan 4.

PMID:
21211963
17.

Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.

Siraj AK, Ibrahim M, Al-Rasheed M, Bu R, Bavi P, Jehan Z, Abubaker J, Murad W, Al-Dayel F, Ezzat A, El-Solh H, Uddin S, Al-Kuraya K.

Ann Hematol. 2007 Dec;86(12):887-95. Epub 2007 Aug 22.

PMID:
17712558
18.

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.

Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.

PMID:
20143151
19.

MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.

Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS.

Carcinogenesis. 2007 Sep;28(9):1985-90. Epub 2007 Jul 9.

PMID:
17621591
20.

Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.

Shen M, Purdue MP, Kricker A, Lan Q, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK.

Haematologica. 2007 Sep;92(9):1180-5. Epub 2007 Aug 1.

Supplemental Content

Support Center